ABBV-319: A First-In-Class CD19-targeting Glucocorticoid Receptor Modulator (GRM) Agonist Antibody-Drug Conjugate (ADC) for the Treatment of B-cell Malignancies

Name: ABBV-319: A First-In-Class CD19-targeting Glucocorticoid Receptor Modulator (GRM) Agonist Antibody-Drug Conjugate (ADC) for the Treatment of B-cell Malignancies
Creator: 暂无描述
License: 暂无描述

NIAID Data Ecosystem2026-05-02 收录

下载链接：

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249543

下载链接

链接失效反馈

官方服务：

资源简介：

This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

创建时间：

2024-10-01